Crescita Therapeutics Inc.

CRRTF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$2,750-$1,986$862-$1,105
Dep. & Amort.$1,366$1,506$1,471$1,379
Deferred Tax-$14$456-$458$96
Stock-Based Comp.$181$82$221$272
Change in WC$3,911$1,808-$3,715-$1,466
Other Non-Cash$31$210$599-$773
Operating Cash Flow$2,725$2,076-$1,020-$1,597
Investing Activities
PP&E Inv.-$1,185-$133-$229-$346
Net Acquisitions$0$0-$61$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$834$0-$61-$500
Investing Cash Flow-$2,019-$133-$290-$846
Financing Activities
Debt Repay.-$441-$408-$1,373-$349
Stock Issued$0$0$0$0
Stock Repurch.-$320-$393-$429-$101
Dividends Paid$0$0$0$0
Other Fin. Act.-$100$19-$44-$50
Financing Cash Flow-$861-$782-$1,846-$500
Forex Effect$43-$14$63-$7
Net Chg. in Cash-$112$1,147-$3,093-$2,950
Supplemental Information
Beg. Cash$9,385$8,238$11,331$14,281
End Cash$9,273$9,385$8,238$11,331
Free Cash Flow$1,540$1,943-$1,249-$1,943
Crescita Therapeutics Inc. (CRRTF) Financial Statements & Key Stats | AlphaPilot